The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia
Clinical trial NCT03944109 · COMPLETED
Trial details
- NCT number
- NCT03944109
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-20
- Primary completion
- 2020-12-22
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.